Saturday 17 October 2026
Export OPRX’s income statement to Excel — free account
OptimizeRx Corp.
OPRX Healthcare Health Information Services
OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
8.50
0.35
−3.95%
Follow OPRX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
45.41 | 0.00 | 0.00 | 0.00 | 2,736.12 | 0.00 | 0.00 | 529.95 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 5 | 2 | 4 | 7 | 3 | 3 | 8 | 4 | 3 |
Altman Z-Score |
3.31 | 0.82 | 2.25 | 21.47 | 67.83 | 27.00 | 6.84 | 10.54 | 4.65 | 1.39 |
P/S ratio |
2.08 | 0.97 | 3.36 | 4.88 | 17.46 | 10.67 | 5.59 | 5.60 | 3.74 | 3.10 |
P/FCF ratio |
12.11 | 20.05 | 0.00 | 29.25 | 4,458.46 | 0.00 | 0.00 | 169.39 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
3.37 | 1.48 | 1.53 | 18.15 | 18.48 | 5.39 | 4.07 | 2.06 | (6.22) | (2.99) |
Beneish M-Score |
(2.77) | (3.12) | (3.03) | (3.25) | (2.20) | (1.25) | (2.32) | (0.30) | (2.57) | (4.26) |
P/Operating CF |
32.09 | 449.01 | (38.42) | 108.60 | (801.76) | (178.22) | (91.67) | 127.39 | 8,724.69 | (57.91) |
P/B ratio |
1.77 | 0.76 | 1.90 | 2.41 | 8.14 | 9.25 | 3.06 | 6.44 | 7.29 | 3.08 |
Price to Tangible BV |
13.68 | 145.03 | 0.00 | 3.37 | 10.10 | 19.99 | 8.50 | 12.48 | 8.34 | 3.42 |
EV/Sales |
2.10 | 1.18 | 3.67 | 3.69 | 16.08 | 10.44 | 4.85 | 5.18 | 3.32 | 2.20 |
EV/EBITDA |
13.41 | 0.00 | 0.00 | 0.00 | 423.69 | 0.00 | 0.00 | 221.34 | 0.00 | 0.00 |
EV/Operating CF |
12.28 | 22.16 | (36.30) | 21.64 | 1,357.68 | (71.62) | (71.78) | 138.68 | (27.20) | (36.54) |
EV/FCF |
12.24 | 24.43 | (33.01) | 22.15 | 4,106.99 | (56.96) | (36.70) | 156.69 | (23.34) | (20.88) |
Quick Ratio |
2.91 | 2.77 | 2.86 | 11.47 | 11.69 | 2.83 | 4.30 | 3.63 | 2.41 | 2.75 |
Current Ratio |
3.04 | 2.89 | 3.04 | 11.74 | 12.29 | 3.28 | 4.44 | 3.72 | 2.49 | 2.78 |
Net Debt/EBITDA |
0.13 | (2.28) | (0.94) | 7.20 | (36.26) | 61.32 | 7.26 | (17.95) | 2.84 | 5.23 |
Debt/Assets |
14.51% | 19.17% | 19.76% | 0.17% | 0.23% | 0.74% | 1.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.20 | 0.28 | 0.29 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.63 | 0.52 | 0.45 | 0.45 | 0.61 | 0.74 | 0.60 | 1.22 | 1.14 | 0.65 |
Operating CF/Net income |
3.65 | (0.24) | 0.41 | (0.93) | 1.92 | 2.86 | 0.53 | 3.50 | 0.70 | 0.30 |
Capex/Depreciation |
0.01 | (0.09) | (0.33) | (0.12) | (0.25) | (0.06) | (1.35) | (0.29) | (0.13) | (1.49) |
Interest Coverage |
2.21 | (2.22) | (18.16) | (14.42) | 21.24 | (31.13) | (12.82) | 3.90 | (82.24) | (37.39) |
| 4.18% | (16.51%) | (13.90%) | (8.88%) | 0.42% | (4.65%) | (9.93%) | 1.83% | (29.99%) | (18.37%) | |
| 2.95% | (11.34%) | (11.05%) | (8.30%) | 0.38% | (3.77%) | (7.69%) | 1.30% | (19.81%) | (12.94%) | |
ROIC |
5.60% | (6.28%) | (11.08%) | (14.71%) | 0.48% | (3.34%) | (8.69%) | 1.18% | (121.25%) | (127.11%) |
Return on Tangible Assets |
11.78% | (56.70%) | (48.00%) | (12.66%) | 0.36% | (9.60%) | (14.82%) | 1.94% | (38.73%) | (23.03%) |
Average Days of Receivables |
128.43 | 151.39 | 190.30 | 129.49 | 147.69 | 150.72 | 110.07 | 111.15 | 103.26 | 144.11 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
52.28% | 66.50% | 81.12% | 78.84% | 54.15% | 55.79% | 72.57% | 55.22% | 63.97% | 72.71% |
Intangible Assets out of Total Assets |
0.63 | 0.68 | 0.70 | 0.27 | 0.18 | 0.45 | 0.51 | 0.36 | 0.08 | 0.07 |
Share Based Compensation of Revenue |
6.36% | 12.45% | 19.18% | 25.21% | 8.96% | 7.33% | 9.19% | 11.89% | 7.44% | 7.22% |
Graham Net Nets |
0.07 | 0.00 | (0.01) | 0.30 | 0.10 | 0.05 | 0.11 | 0.08 | 0.12 | 0.27 |
Graham Number |
6.48 | 0.00 | 0.00 | 0.00 | 1.97 | 0.00 | 0.00 | 0.89 | 0.00 | 0.00 |
Earnings Yield |
2.20% | (22.63%) | (7.19%) | (3.68%) | 0.04% | (0.48%) | (2.14%) | 0.19% | (4.55%) | (6.17%) |
Free Cash Flow Yield |
8.26% | 4.99% | (3.31%) | 3.42% | 0.02% | (1.72%) | (2.36%) | 0.59% | (3.80%) | (3.39%) |
Revenue per Share |
5.90 | 5.04 | 4.18 | 3.51 | 3.56 | 2.92 | 1.84 | 1.96 | 1.24 | 0.78 |
Operating CF per Share |
1.01 | 0.27 | (0.42) | 0.60 | 0.04 | (0.43) | (0.12) | 0.07 | (0.15) | (0.05) |
Capex per Share |
0.00 | (0.02) | (0.05) | (0.01) | (0.03) | (0.01) | (0.12) | (0.01) | 0.00 | (0.04) |
Free Cash Flow per Share |
1.01 | 0.24 | (0.47) | 0.59 | 0.01 | (0.43) | (0.24) | 0.06 | (0.15) | (0.08) |
Cash per Share |
1.26 | 0.73 | 0.81 | 4.17 | 4.92 | 0.71 | 1.41 | 0.82 | 0.52 | 0.71 |
Shareholders Equity per Share |
6.91 | 6.40 | 7.39 | 7.09 | 7.63 | 3.37 | 3.35 | 1.70 | 0.63 | 0.79 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.91 | 6.40 | 7.39 | 7.09 | 7.63 | 3.37 | 3.35 | 1.70 | 0.63 | 0.79 |
Free Cash Flow |
18.78 | 4.44 | (8.10) | 10.41 | 0.24 | (6.44) | (3.25) | 0.70 | (1.52) | (0.82) |
Working Capital |
43.45 | 35.32 | 36.45 | 90.18 | 105.74 | 22.83 | 21.03 | 11.50 | 5.27 | 6.51 |
Capital Expenditures |
0.07 | (0.45) | (0.86) | (0.25) | (0.49) | (0.12) | (1.59) | (0.09) | (0.04) | (0.35) |
Net Current Asset Value |
16.09 | (0.20) | (2.49) | 90.04 | 105.51 | 22.51 | 15.37 | 9.14 | 5.27 | 6.51 |
EV/EBIT |
19.65 | 0.00 | 0.00 | 0.00 | 2,729.65 | 0.00 | 0.00 | 609.96 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.06 | 0.00 | 0.00 | 0.05 |
Price to Operating Income |
19.45 | 0.00 | 0.00 | 0.00 | 2,963.25 | 0.00 | 0.00 | 659.43 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
51.29 | 34.43 | 17.54 | 14.72 | 13.67 | 13.24 | 6.68 | 2.12 | 1.94 | 1.36 |
Cash ROIC |
10.59% | 2.72% | (4.59%) | 5.19% | 0.11% | (10.56%) | (5.05%) | 2.56% | (13.42%) | (5.49%) |
Accounts Receivable Turnover |
2.85 | 2.44 | 2.41 | 2.66 | 2.87 | 3.42 | 3.55 | 4.29 | 3.74 | 2.62 |
Accounts Payable Turnover |
18.90 | 14.94 | 15.16 | 21.78 | 41.88 | 34.57 | 20.26 | 20.73 | 14.94 | 5.93 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
16.66 | 24.03 | 28.40 | 24.09 | 8.63 | 11.75 | 19.65 | 16.67 | 27.03 | 39.50 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
38.36 | 37.75 | 29.72 | 23.48 | 21.34 | 12.65 | 6.94 | 4.94 | 3.25 | 2.95 |
Average Payables |
1.90 | 2.19 | 1.89 | 1.08 | 0.61 | 0.56 | 0.45 | 0.43 | 0.41 | 0.58 |
Average Assets |
174.04 | 177.27 | 159.01 | 137.82 | 100.66 | 58.48 | 40.85 | 17.41 | 10.62 | 11.90 |
Average Common Equity |
122.65 | 121.78 | 126.33 | 128.75 | 90.68 | 47.42 | 31.66 | 12.34 | 7.02 | 8.38 |
Columns are period end dates